Global Research Trends of World Health Organization's Top Eight Emerging Pathogens

Overview

Journal Global Health

Publisher Biomed Central

Specialties Health Services
Public Health

Date 2017 Feb 10

PMID 28179007

Citations 92

Authors

Waleed M Sweileh

Affiliations

Soon will be listed here.

Abstract

Background: On December 8, 2015, World Health Organization published a priority list of eight pathogens expected to cause severe outbreaks in the near future. To better understand global research trends and characteristics of publications on these emerging pathogens, we carried out this bibliometric study hoping to contribute to global awareness and preparedness toward this topic.

Method: Scopus database was searched for the following pathogens/infectious diseases: Ebola, Marburg, Lassa, Rift valley, Crimean-Congo, Nipah, Middle Eastern Respiratory Syndrome (MERS), and Severe Respiratory Acute Syndrome (SARS). Retrieved articles were analyzed to obtain standard bibliometric indicators.

Results: A total of 8619 journal articles were retrieved. Authors from 154 different countries contributed to publishing these articles. Two peaks of publications, an early one for SARS and a late one for Ebola, were observed. Retrieved articles received a total of 221,606 citations with a mean ± standard deviation of 25.7 ± 65.4 citations per article and an h-index of 173. International collaboration was as high as 86.9%. The Centers for Disease Control and Prevention had the highest share (344; 5.0%) followed by the University of Hong Kong with 305 (4.5%). The top leading journal was Journal of Virology with 572 (6.6%) articles while Feldmann, Heinz R. was the most productive researcher with 197 (2.3%) articles. China ranked first on SARS, Turkey ranked first on Crimean-Congo fever, while the United States of America ranked first on the remaining six diseases. Of retrieved articles, 472 (5.5%) were on vaccine - related research with Ebola vaccine being most studied.

Conclusion: Number of publications on studied pathogens showed sudden dramatic rise in the past two decades representing severe global outbreaks. Contribution of a large number of different countries and the relatively high h-index are indicative of how international collaboration can create common health agenda among distant different countries.

Citing Articles

Cedar virus biology and its applications as a surrogate for highly pathogenic henipaviruses.

Sabir A, Rong L, Broder C, Amaya M Cell Insight. 2025; 3(4):100181.

PMID: 39967899 PMC: 11832809. DOI: 10.1016/j.cellin.2024.100181.

Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses.

Ofodile C, Uzochukwu I, Ezebuo F, Ejiofor I, Adebola M, Okpoli I Viruses. 2025; 17(1).

PMID: 39861906 PMC: 11768584. DOI: 10.3390/v17010117.

Transforming healthcare: Saudi Arabia's vision 2030 healthcare model.

Suleiman A, Ming L J Pharm Policy Pract. 2025; 18(1):2449051.

PMID: 39845746 PMC: 11753010. DOI: 10.1080/20523211.2024.2449051.

Unveiling the global reach of African anthrax research: A bibliometric study.

Elisha I, Onikisateinba A, Joel G, Luka P, Joshua B, Jagab S Sci One Health. 2024; 3:100052.

PMID: 39077387 PMC: 11262261. DOI: 10.1016/j.soh.2023.100052.

The urgency of Marburg therapeutics: preventing local outbreaks from the potential global spread.

Suvvari T, Mahal A, Kandi V, Alotaibi H, Mishra S, Mohapatra R Front Microbiol. 2024; 15:1378314.

PMID: 39011143 PMC: 11248717. DOI: 10.3389/fmicb.2024.1378314.

References

Cox R, McIntyre K, Sanchez J, Setzkorn C, Baylis M, Revie C . Comparison of the h-Index Scores Among Pathogens Identified as Emerging Hazards in North America. Transbound Emerg Dis. 2014; 63(1):79-91. DOI: 10.1111/tbed.12221. View

Li W, Moore M, Vasilieva N, Sui J, Wong S, Berne M . Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426(6965):450-4. PMC: 7095016. DOI: 10.1038/nature02145. View

Bisht H, Roberts A, Vogel L, Bukreyev A, Collins P, Murphy B . Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A. 2004; 101(17):6641-6. PMC: 404098. DOI: 10.1073/pnas.0401939101. View

Tsang K, Ho P, Ooi G, Yee W, Wang T, Chan-Yeung M . A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348(20):1977-85. DOI: 10.1056/NEJMoa030666. View

Vijay R, Perlman S . Middle East respiratory syndrome and severe acute respiratory syndrome. Curr Opin Virol. 2016; 16:70-76. PMC: 4821769. DOI: 10.1016/j.coviro.2016.01.011. View

Ng O, Tan Y . Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development. Hum Vaccin Immunother. 2016; 13(1):186-189. PMC: 5287300. DOI: 10.1080/21645515.2016.1228500. View

Faye O, Diallo M, Diop D, Bezeid O, Ba H, Niang M . Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003. Emerg Infect Dis. 2008; 13(7):1016-23. PMC: 2878230. DOI: 10.3201/eid1307.061487. View

Leblebicioglu H, Sunbul M, Memish Z, Al-Tawfiq J, Bodur H, Ozkul A . Consensus report: Preventive measures for Crimean-Congo Hemorrhagic Fever during Eid-al-Adha festival. Int J Infect Dis. 2015; 38:9-15. DOI: 10.1016/j.ijid.2015.06.029. View

Lorenzo G, Lopez-Gil E, Warimwe G, Brun A . Understanding Rift Valley fever: contributions of animal models to disease characterization and control. Mol Immunol. 2015; 66(1):78-88. DOI: 10.1016/j.molimm.2015.02.001. View

10.

Hunter J, Nguyen D, Aden B, Al Bandar Z, Al Dhaheri W, Abu Elkheir K . Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi. Emerg Infect Dis. 2016; 22(4):647-56. PMC: 4806977. DOI: 10.3201/eid2204.151615. View

11.

Lipsitch M, Cohen T, Cooper B, Robins J, Ma S, James L . Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003; 300(5627):1966-70. PMC: 2760158. DOI: 10.1126/science.1086616. View

12.

Booth C, Matukas L, Tomlinson G, Rachlis A, Rose D, Dwosh H . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003; 289(21):2801-9. DOI: 10.1001/jama.289.21.JOC30885. View

13.

Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

14.

Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A . Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology. 1998; 251(1):28-37. DOI: 10.1006/viro.1998.9367. View

15.

Sweileh W, Shraim N, Zyoud S, Al-Jabi S . Worldwide research productivity on tramadol: a bibliometric analysis. Springerplus. 2016; 5(1):1108. PMC: 4949195. DOI: 10.1186/s40064-016-2801-5. View

16.

Hempelmann E, Tesarowicz I, Oleksyn B . [From onions to artemisinin. Brief history of malaria chemotherapy]. Pharm Unserer Zeit. 2009; 38(6):500-7. DOI: 10.1002/pauz.200900336. View

17.

Al-Hazmi A . Challenges presented by MERS corona virus, and SARS corona virus to global health. Saudi J Biol Sci. 2016; 23(4):507-11. PMC: 4890194. DOI: 10.1016/j.sjbs.2016.02.019. View

18.

Cavanagh D . Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol. 2003; 32(6):567-82. PMC: 7154303. DOI: 10.1080/03079450310001621198. View

19.

Sullivan N, Sanchez A, Rollin P, Yang Z, Nabel G . Development of a preventive vaccine for Ebola virus infection in primates. Nature. 2000; 408(6812):605-9. DOI: 10.1038/35046108. View

20.

Chen Z, Zhang L, Qin C, Ba L, Yi C, Zhang F . Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 2005; 79(5):2678-88. PMC: 548443. DOI: 10.1128/JVI.79.5.2678-2688.2005. View